Related Experiment Video
Updated: Mar 15, 2026

Collecting Sleep, Circadian, Fatigue, and Performance Data in Complex Operational Environments
Published on: August 8, 2019
Digital insomnia therapeutic as a workplace performance solution for improving productivity
Jonathan P Russell1, Arjun Teotia1, David A Kalmbach1
1Henry Ford Health, Michigan State University Health Sciences, United States.
Objectives:
Insomnia is highly prevalent in the workforce and impairs productivity. Cognitive behavioral therapy for insomnia (CBT-I) is the gold-standard treatment but has limited scalability. Digital CBT-I (dCBT-I) offers scalable alternative, yet its effects on workplace productivity are not well established. This study investigated whether dCBT-I produces significant and occupationally meaningful improvements in productivity.
Methods:
This study is a secondary analysis of a RCT (clinicaltrials.gov: NCT02988375) with 444 employed adults with DSM-5 insomnia disorder and no other sleep disorders were included (245 in dCBT-I, 199 in sleep education). The Work Productivity and Activity Impairment questionnaire, adapted to a specific health problem with insomnia as the health problem (WPAI-SHP), assessed productivity outcomes. A mixed-effects model evaluated changes in productivity via total work impairment (the primary outcome). Logistic regressions tested the odds of achieving occupationally meaningful improvements (reductions of ≥15% in total work impairment, ≥10% in presenteeism, and ≥5% in absenteeism).
Results:
Participants receiving dCBT-I demonstrated significantly greater reductions in total work impairment than controls at post-treatment (between-group difference = 16.5 percentage points, 95% CI [11.2, 21.8], p < .001). The odds of achieving a 15% reduction in total work impairment were higher in the dCBT-I group (OR = 2.7 95% CI [1.7, 4.3]).
Conclusions:
dCBT-I produced significant improvements in workplace productivity with estimated annual productivity savings of $12,376 per employee. These findings suggest dCBT-I may provide a cost-effective strategy to improve workforce health and productivity, supporting investment in digital mental health tools by employers and health systems.
More Related Videos
10:16Human Circadian Phenotyping and Diurnal Performance Testing in the Real World
Published on: April 7, 2020
12:22Mindfulness in Motion MIM: An Onsite Mindfulness Based Intervention MBI for Chronically High Stress Work Environments to Increase Resiliency and Work Engagement
Published on: July 1, 2015
Related Concept Videos
Management of Insomnia
Insomnia
Multiple factors contribute...
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Narcolepsy
Blind Procedures
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...